Lexicon Pharmaceuticals LXRX Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $49.8M+60.2% | $31.08M+2,479% | $1.21M+767% | $139K-53.4% | ||
| $274K-55.5% | $616K+625% | $85K— | $0— | ||
| $49.53M+62.6% | $30.47M+2,620% | $1.12M+706% | $139K-53.4% | ||
| 99.4%+1.4pp | 98%+5.1pp | 92.9%-7.1pp | 100%0.0pp | ||
| $61.12M-27.6% | $84.48M+43.5% | $58.89M+11.5% | $52.82M-4.1% | ||
| $37.32M-73.9% | $143.1M+25.5% | $113.98M— | —— | ||
| $98.71M-56.7% | $228.2M+31.9% | $172.96M+71.4% | $100.9M+15.5% | ||
| -$48.91M+75.2% | -$197.12M-14.8% | -$171.75M-70.5% | -$100.76M-15.7% | ||
| -98.2%+536pp | -634.2%+13,619pp | -14,253.1%+58,236pp | -72,489.2%-43,264pp | ||
| $8.33M-35.5% | $12.92M+28.5% | $10.06M+262% | $2.78M+247% | ||
| $6.91M-43.8% | $12.29M+59.0% | $7.73M+384% | $1.6M+1,091% | ||
| —— | $0— | $0— | $0— | ||
| -$50.34M+74.9% | -$200.4M-13.1% | -$177.12M-73.7% | -$101.94M-16.2% | ||
| -101.1%+544pp | -644.8%+14,054pp | -14,698.7%+58,642pp | -73,341%-43,892pp | ||
| -$0.14+78.1% | -$0.64+20.0% | -$0.80— | —— | ||
| -$48.29M+75.4% | -$196.58M-14.8% | -$171.2M-70.6% | -$100.33M-15.6% | ||
| -97%+536pp | -632.5%+13,575pp | -14,207.1%+57,975pp | -72,182%-43,055pp | ||
| -$48.91M+75.2% | -$197.12M-14.8% | -$171.75M-70.5% | -$100.76M-15.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Lexicon Pharmaceuticals's revenue?
- Lexicon Pharmaceuticals (LXRX) generated $69.6M in revenue over the trailing twelve months, up 123.1% year over year.
- Is Lexicon Pharmaceuticals profitable?
- Lexicon Pharmaceuticals is not currently profitable: it reported a net loss of $26.1M over the trailing twelve months, a -37.5% net margin.
- What are Lexicon Pharmaceuticals's profit margins?
- Gross margin is 99.5% and operating margin is -34.8%, with a -37.5% net margin.
- What is Lexicon Pharmaceuticals's earnings per share?
- Lexicon Pharmaceuticals's diluted EPS over the trailing twelve months is $-0.07.
- Where does Lexicon Pharmaceuticals's income statement data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
